Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function.
Robert EdforsAnders SahlénKarolina SzummerHenrik RenlundMarie EvansJuan-Jesus CarreroJonas SpaakStefan K JamesBo LagerqvistChristoph VarenhorstTomas JernbergPublished in: Heart (British Cardiac Society) (2018)
Treatment with ticagrelor as compared with clopidogrel in patients with MI was associated with lower risk for the composite of death, MI or stroke and a higher bleeding risk across all strata of eGFR. Of caution, bleeding events were more abundant in patients with eGFR<30.
Keyphrases
- percutaneous coronary intervention
- acute coronary syndrome
- acute myocardial infarction
- atrial fibrillation
- antiplatelet therapy
- st segment elevation myocardial infarction
- small cell lung cancer
- st elevation myocardial infarction
- coronary artery disease
- tyrosine kinase
- epidermal growth factor receptor
- heart failure
- skeletal muscle
- adipose tissue
- blood brain barrier
- insulin resistance